MODERN STRATEGY OF BARRETT’S ESOPHAGUS ENDOSCOPIC DIAGNOSTICS, TREATMENT AND FOLLOW-UP
Abstract
The aim of the study is the rationalizing of the strategy change of endoscopic diagnostics, follow-up and treatment of patients with Barrett’s esophagus. From 2007 to 2015 Barrett’s mucosa has been defined during upper endoscopy in 111 patients of the main group. Another 12 patients with Barrett’s esophagus were followed-up from 1995 to 2010-2015. Endoscopic argon-plasma coagulation of the abnormal areas of the Barrett’s mucosa was performed in 17, endoscopic mucosal resection in 2 patients. The result was the recovery of stratified squamous esophageal epithelium. The remaining 92 patients were treated only by drug therapy. None of the 111 patients in the main group and as well as 12 patients followed-up since 1995, had any progression of Barrett’s esophagus of any length metaplasia segment, nor on the expression of intestinal metaplasia or dysplasia. Extensive experience in endoscopic diagnostics of esophageal diseases and the use of high resolution and high definition endoscopes with a variety of additional features are the base of a correct diagnosis of Barrett’s esophagus.
About the Authors
E. A. Godzhello
The Federal State Budgetary Scientific Institution «Petrovsky National Research Center of Surgery»
Russian Federation
Russian Federation
M. V. Khrustaleva
The Federal State Budgetary Scientific Institution «Petrovsky National Research Center of Surgery»
Russian Federation
Russian Federation
N. A. Bulganina
The Federal State Budgetary Scientific Institution «Petrovsky National Research Center of Surgery»
Russian Federation
Russian Federation
D. G. Shatveryan
The Federal State Budgetary Scientific Institution «Petrovsky National Research Center of Surgery»
Russian Federation
Russian Federation
M. A. Dekhtyar
The Federal State Budgetary Scientific Institution «Petrovsky National Research Center of Surgery»
Russian Federation
Russian Federation
References
1. Koppert L., Wijnhoven B., van Dekken H., Tilanus H., Dinjens W. The molecular biology of esophageal adenocarcinoma. J Surg Oncol (2005) 92 (3): 169-90. PMID 16299787.
2. Levine D.S., Blount P. L., Rudolph R. E., et al. Safety of a systematic endoscopic biopsy protocol in patients with Barrett’s esophagus. Am J Gastroenterol 2000; 95: 1152-7
3. Май Андреа. Эндоскопическая диагностика и лечение пищевода Барретта с неоплазией и без. Эндоскопия 4, 2012: 11-16.
4. Aoki T., Kawaura Y., Kouzu T., et al. Report of the Research Committee on the Definition of Barrett’s Esophagus (Epithelium) [in Japanese]. In: Sugimachi K, editor. Reports of the research committees of The Japanese Society for Esophageal Diseases. Chiba: Japanese Society of Esophageal Diseases; 2000: 20-23.
5. Choi do W., Oh S. N., Baek S. J. et al. Endoscopically observed lower esophageal capillary patterns. Korean J. Intern. Med. - 2002. - Vol. 17, N 4. - P. 245-248.
6. Ивашкин В.Т., Маев И. В., Трухманов А. С. и др. Клинические рекомендации Российской Гастроэнтерологической Ассоциации по диагностике и лечению пищевода Барретта, 2014.
7. Vahabzadeh B., Seetharam A. B., Cook M. B., et al. Validation of the Prague C & M criteria for the endoscopic grading of Barrett’s esophagus by gastroenterology trainees: a multicenter study. Gastrointest Endosc 2012; 75: 236-41.
8. Yousef F., Cardwell C., Cantwell M. M., et al. The incidence of esophageal cancer and highgrade dysplasia in Barrett’s esophagus: a systematic review and meta-analysis. Am J Epidemiol 2008; 168: 237-249.
Review
For citations:
Godzhello E.A., Khrustaleva M.V., Bulganina N.A., Shatveryan D.G., Dekhtyar M.A. MODERN STRATEGY OF BARRETT’S ESOPHAGUS ENDOSCOPIC DIAGNOSTICS, TREATMENT AND FOLLOW-UP. Experimental and Clinical Gastroenterology. 2017;(4):15-21. (In Russ.)
Views:
232
Email this article 